Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Journal of Inherited Metabolic Disease|January 5, 2002
Lessons learned from the development of enzyme therapy for Gaucher diseaseJ A Barranger, E O'RourkeAnalytical Biochemistry|June 1, 1984
Nonenzymatic decarboxylation of pyruvateG Constantopoulos, J A BarrangerBiochemical Medicine|February 1, 1983
Pyruvate decarboxylating activity in extracts from pigeon liver acetone powderG Constantopoulos, J A BarrangerClinica Chimica Acta; International Journal of Clinical Chemistry|October 1, 1979
125Iodine labeling of beta-hexosaminidase A without modifying its propertiesJ W Kusiak, J A BarrangerArchives of Neurology|February 1, 1980
Neurologic complications of Gaucher's disease, type 3R N Nishimura, J A BarrangerAJR. American Journal of Roentgenology|September 1, 1984
Enlarged phalangeal nutrient foramina in Gaucher disease and beta-thalassemia majorI J Fink, B Pastakia, J A BarrangerExperimental Cell Research|April 1, 1984
Effect of mycoplasma infection on pyruvate dehydrogenase complex activity of normal and pyruvate dehydrogenase complex-deficient fibroblastsG J McGarrity, G Constantopoulos, J A BarrangerThe American Journal of Medicine|March 1, 1986
Gaucher's disease in a patient with chronic active hepatitisS C Patel, G L Davis, J A BarrangerArchives of Pathology & Laboratory Medicine|January 1, 1985
Vascular involvement in type 3 neuronopathic Gaucher's diseaseE R Wilson, N W Barton, J A BarrangerGene Therapy|August 1, 1995
Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotypeT Ohashi, R Matalon, J A Barranger, et al.Pageof 11